医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NCKU Alumni in Malaysia Run for Charity

2016年10月13日 AM10:48
このエントリーをはてなブックマークに追加


 

TAINAN, Taiwan

Secretariat Ackum, the alumni association of NCKU in Malaysia, hosted the ACKU Charity Run 2016, which highlighted the value of ethnicity-friendly, at the University of Malaya (UM) on the morning of July 30.

ACKU Charity Run 2016 is a fundraising event for cancer research in the UM Special Center helping deprived patients with better access to cancer treatment.

Over 2,500 runners came in support the event, raising a total of US$25,000 for breast cancer patients.

For NCKU, the bond between alumni and their alma mater is closer than ever before. With a growing community of 140,000+ grads around the world, NCKU is developing its alumni networks to amplify the impacts and create social engagement.

NCKU President Huey-Jen Jenny Su flied from Taiwan to join the run which is the biggest event for NCKU alumni in Asia.

President Su’s visit to Malaysia marked an important milestone in the development of the relations between Taiwan and Malaysia.

In the past ten years, NCKU and the UM have fostered close partnership and this beautiful friendship between the two universities will continue to grow and thrive, according to Su.

She noted, the success of last year’s event made holding another charity run for helping more people in need. The fund raised last year was to support orphans and this year we have commitment to the patients who suffered from breast cancer.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161012006407/en/

CONTACT

National Cheng Kung University
Sonia Chuang, +886-6-275-7575 Ext.
50042
News Center
Fax: +886-6-238-9919
E-Mail: sonia20@mail.ncku.edu.tw
NCKU
news: http://news-en.secr.ncku.edu.tw/bin/home.php

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report